Oxidative stress and nitric oxide in kidney function

Current Opinion in Nephrology and Hypertension

Volumn 15, Issue 1, 2006, Pages 72-77

  Araujo, Magali ^a   Welch, William J ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Nitric oxide; Oxygen consumption; Reactive oxygen species; Renal failure; Renal microcirculation

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

DIABETIC NEPHROPATHY; HUMAN; INSULIN RESISTANCE; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; KIDNEY TUBULE EPITHELIUM; MICROCIRCULATION; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TISSUE INJURY; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULARIZATION;

DIABETIC NEPHROPATHIES; HUMANS; KIDNEY; KIDNEY FAILURE; NITRIC OXIDE; OXIDATIVE STRESS; OXYGEN CONSUMPTION; REPERFUSION INJURY;

EID: 33645733086     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000191912.65281.e9     Document Type: Review

References (49)

1. Pittner J, Wolgast M, Casellas D, Persson AEG. Increased shear stress-released NO and decreased endothelial calcium in rat isolated perfused juxtamedullary nephrons. Kidney Int 2005; 67:227-236.
2. Patzak A, Lai EY, Mrowka R, et al. AT1 receptors mediate angiotensin II-induced release of nitric oxide in afferent arterioles. Kidney Int 2004; 66:1949-1958.
3. 2 receptor. Am J Physiol Renal Physiol 2005; 288:F1191-F1120.
4. Ozawa Y, Hayashi K, Kanda T, et al. Impaired nitric oxide- and endothelium-derived hyperpolarizing factor-dependent dilation of renal afferent arteriole in Dahl salt-sensitive rats. Nephrology 2004; 9:272-277.
5. 2+ signaling in afferent arterioles. Am J Physiol Renal Physiol 2005; Jun 7 [Epub ahead of print]. This study showed that changes in angiotensin II-dependent resistance mediated by downstream oxidative signaling occur immediately.
6. Rajapakse NW, Sampson AK, Eppel GA, Evans RG. Angiotensin II and nitric oxide in neural control of intrarenal blood flow. Am J Physiol Regul Integr Comp Physiol 2005; 289:R745-R754.
7. Liu R, Carretero OA, Ren Y, Garvin JL. Increased intracellular pH at the macula densa activates nNOS during tubuloglomerular feedback. Kidney Int 2005; 67:1837-1843. This study utilized an elegant in vitro isolated juxtaglomerular apparatus preparation to test the role of intracellular pH in macula densa nitric oxide release. This is the first report that pH may be part of the regulation of neuronal NOS in the macula densa.
8. Juncos R, Garvin JL. Superoxide enhances Na-K-2Cl cotransporter activity in the thick ascending limb. Am J Physiol Renal Physiol 2005; 288:F982-F987. This was one of the first studies to define a role for superoxide in loop of Henle epithelial transport.
9. Herrera M, Garvin JL. A high-salt diet stimulates thick ascending limb eNOS expression by raising medullary osmolality and increasing release of endothelin-1. Am J Physiol Renal Physiol 2005; 288:F58-F64.
10. Morishita T, Tsutsui M, Shimokawa H, et al. Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proc Nat Acad Sci U S A 2005; 102:10616-10621. This is the first report from the triple knockout mouse deficient in all isoforms of NOS. Though this report identifies a specific renal phenotype, this mouse model should be valuable in renal function studies evaluating nitric oxide and oxidative stress.
11. Adler S, Huang H. Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 2004; 287:F907-F913. This study showed a possible mechanism for the decreased oxygen consumption in nitric oxide suppressed animal model.
12. Chen Y, Gill PS, Welch WJ. Oxygen availability limits renal NADPH-dependent superoxide production. Am J Physiol Renal Physiol 2005; 289:F749-F753. This was a novel study that may explain limits to superoxide production in the renal medulla.
13. Deng A, Miracle CM, Suarez JM, et al. Oxygen consumption in the kidney: Effects of nitric oxide synthase isoforms and angiotensin II. Kidney Int 2005; 68:723-730. This study was the first to report oxygen metabolism on specific nephron segments, demonstrating that neuronal NOS is linked to oxygen consumption in the kidney and specifically in the proximal tubule. This study opened the quest for evaluation of oxygen usage in various nephron segments.
14. Postovit LM, Sullivan R, Adams MA, Graham CH. Nitric oxide signaling and cellular adaptations to changes in oxygenation. Toxicology 2005; 208: 235-248.
15. Xu W, Liu L, Charles IG, Moncada S. Nitric oxide induces coupling of mitochondrial signaling with the endoplasmic reticulum stress response. Nat Cell Biol 2004; 6:1129-1134.
16. Sindhu RK, Ehdaie A, Farmand F, et al. Expression of catalase and glutathione peroxidase in renal insufficiency. Bioch Biophysica Acta 2005; 1743:86-92.
17. Shimizu MHM, Coimbra TM, Araujo M, et al. N-acetylcysteine attenuates the progression of chronic renal failure. Kidney Int 2005; July 30 [Epub ahead of print].
18. Ivanowsky O, Szumilak D, Nguyen-Koya T, et al. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice. Kidney Int 2005; 67:2288-2294.
19. Pawlak K, Pawlak D, Mysliwiec M. Cn/Zn superoxide dismutase plasma levels as a new useful clinical biomarker of 19oxidative stress in patients with end-stage renal disease. Clin Biochem 2005; 38:700-705.
20. Zachwieja J, Zaniew M, Bobkowski W, et al. Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis. Pediatr Nephrol 2005; 20:725-731.
21. Scalera F, Kielstein JT, Martens-Lobenhoffer J, et al. Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase. J Am Soc Nephrol 2005; 16:892-898.
22. Okubo K, Hayashi K, Wakino S, et al. Role of asymmetrical dimethylarginine in renal microvascular endothelial dysfunction in chronic renal failure with hypertension. Hypertens Res 2005; 28:181-189.
23. Ravani P, Tripepi G, Malberti F, et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. J Am Soc Nephrol 2005; 16:2449-2455. This study advanced consideration for plasma ADMA as a risk marker for progression of renal failure, yet it did not clearly establish a cause and effect role for ADMA.
24. Fliser D, Kronenmberg F, Kielstein JT, et al. Asymmetric dimethylarginine and progression of chronic disease: the mild to moderate kidney disease study. J Am Soc Nephrol 2005; 16:2456-2461.
25. Wang J, Sim AS, Wang XL, et al. Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease. Atherosclerosis 2005; June 3 [Epub ahead of print].
26. Kurata H, Takaoka M, Kubo Y, et al. Protective effect of nitric oxide in ischemia/ reperfusion-induced renal injury and endothelin-1 overproduction. Eur J Phamacol 2005; 51 7:232-239.
27. Efrati S, Averbukh M, Berman S, et al. N-acetylcysteine ameliorates lithium-induced renal failure in rats. Nephrol Dial Transplant 2005; 20:65-70.
28. Fuller TF, Freise CE, Feng S, Niemann CU. Ischemic preconditioning improves rat kidney graft function after severe ischemia/reperfusion injury. Transplant Proc 2005; 37:377-378.
29. Sun K, Kiss E, Bedke J, et al. Role of xantine oxireductase in experimental acute renal-allograft rejection. Transplantaton 2004; 77:1683-1692.
30. Chander V, Chopra K. Molsidomine, a nitric oxide donor and L-arginine protects against rhabdomyolysis-induced myoglobinuric acute renal failure. Biochem Biophys Acta 2005; 1723:208-214.
31. Himmelfarb J, Mcmonagle E, Freedman S, et al. Oxidative stress is increased in critically ill patients with acute renal failure. J Am Soc Nephrol 2005; 15:2449-2456.
32. Tahara M, Nakayama M, Jin MG, et al. A radical scavenger, Edaravone protects canine kidneys from ischemia-reperfusion injury after 72 hours of cold preservation and autotransplantation. Transplantation 2005; 80:213-221.
33. Singh D, Chander V, Chopra K. Protective effect of catechin on ischemia-reperfusion-induced renal injury in rats. Pharmacol Rep 2005; 57:70-76.
34. Erbas H, Aydogdu N, Kaymar K. Effects of N-acetylcysteine on arginase, ornithine and nitric oxide in renal ischemia-reperfusion injury. Pharmacol Res 2004; 50:523-527.
35. Jo SK, Hu X, Yuen PST, et al. Delayed DMSO administration protects the kidney from mercuric chloride-induced injury. J Am Soc Nephrol 2005; 15:2648-2654.
36. Jeong GY, Chung KY, Lee WJ, et al. The effect of a nitric oxide donor on endogenous endothelin-1 expression in renal ischemia/reperfusion injury. Transpl Proc 2004; 36:1943-1945.
37. Hirayama A, Nagase, Ueda A, et al. In vivo imaging of oxidative stress in ischemia-reperfusion renal injury using electron paragmagnetic resonance. Am J Physiol Renal Physiol 2005; 288:F597-F603. This innovative study quantified oxidative stress in vivo in an animal model of renal ischemia/reperfusion. Continuous measurement of organ antioxidant activity can be monitored and quantified with the use of electron paramagnetic resonance images. This method should be useful in many applications evaluating progressive oxidative stress-related disorders.
38. Yamasowa H, Shimizu S, Inoue T, et al. Endothelial nitric oxide contributes to the renal protective effects of ischemic preconditioning. J Pharmacol Exp Ther 2005; 312:153-159. This report identifies how ischemic preconditioning protects against oxidative damage by stimulation of nitric oxide derived from endothelial NOS. The beneficial effects of ischemic preconditioning were prevented both in NOS-inhibited mice and in endothelial NOS knockout mice.
39. Thomson SC, Deng A, Komine N, et al. Early diabetes as a model for testing the regulation of juxtaglomerular NOS-I. Am J Physiol Renal Physiol 2004; 287:F732-F738. This study provided a greater explanation for the role of neuronal NOS in diabetic hyperfiltration by evaluating TGF in addition to whole kidney GFR. The lack of control of neuronal NOS in diabetes by TGF is provocative and accounts for increased GFR.
40. Komers R, Lindsley JN, Oyama TT, Anderson S. Effects of long-term inhibition of neuronal nitric oxide synthase (NOS1) in uninephrectomized diabetic rats. Nitric Oxide 2004; 11:147-155.
41. Erdely A, Freshour G, Maddox DA, et al. Renal disease in rats with Type 2 diabetes is associated with decreased renal nitric oxide production. Diabetologia 2004; 47:1672-1676.
42. Iino K, Iwase M, Sonoki K, et al. Combination treatment of vitamin C and desferrioxamine suppresses glomerular superoxide and prostaglandin E production in diabetic rats. Diabetes Obes Metab 2005; 7:106-109.
43. Gealekman O, Brodsky SV, Zhang F, et al. Endothelial dysfunction as a modifier of angiogenic response in Zucker diabetic fat rat: amelioration with Ebselen. Kidney Int 2004; 66:2337-2347.
44. Chander PN, Gealekman O, Brodsky SV, et al. Nephropathy in Zucker diabetic fat rat is associated with oxidative and nitrosative stress: prevention by chronic therapy with a peroxynitrite scavenger ebselen. J Am Soc Nephrol 2004; 15:2391-2403.
45. Yasuda G, Kuji T, Hasegawa K, et al. Safety and efficacy of fluvastatin in hyperlipidemic patients with chronic renal disease. Ren Fail 2004; 26: 411-418.
46. Chiarelli F, Santilli F, Sabatino G, et al. Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy. Pediatr Res 2004; 56:720-725.
47. Bhatti F, Mankhey RW, Asico L, et al. Mechanisms of antioxidant and pro-oxidant effects of α-lipoic acid in the diabetic and nondiabetic kidney. Kidney Int 2005; 67:1371-1380.
48. Satoh M, Fujimoto S, Haruna Y, et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetes nephropathy. Am J Physiol Renal Physiol 2005; 288:F1144-F1152. This describes the novel result that superoxide in diabetes is partially generated by uncoupled NOS. Whereas uncoupling of NOS has been shown in controlled conditions this is one of the first to show a role in a pathological model. The hypothesis is further supported by evidence of reduced plasma levels of tetrahydrobiopterin in diabetic rats.
49. Fujita A, Sasaki H, Ogawa K, et al. Increased gene expression of antioxidant enzymes in KKAγ diabetic mice but not in STZ diabetic mice. Diabetes Res Clin Pract 2005; 69:113-119.